Alessandro Tessitore1, Gabriella Santangelo2, Rosa De Micco3, Carmine Vitale4, Alfonso Giordano5, Simona Raimo6, Daniele Corbo7, Marianna Amboni8, Paolo Barone9, Gioacchino Tedeschi10. 1. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy. Electronic address: alessandro.tessitore@unina2.it. 2. Neuropsychology Laboratory, Department of Psychology, Second University of Naples, Caserta, Italy; Istituto di Diagnosi e Cura Hermitage-Capodimonte, Naples, Italy. Electronic address: gabriella.santangelo@unina2.it. 3. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy. 4. Istituto di Diagnosi e Cura Hermitage-Capodimonte, Naples, Italy; Department of Motor Sciences and Health, University of Parthenope, Naples, Italy. 5. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy; Istituto di Diagnosi e Cura Hermitage-Capodimonte, Naples, Italy. 6. Neuropsychology Laboratory, Department of Psychology, Second University of Naples, Caserta, Italy. 7. Department of Neuroscience, University of Parma, Parma, Italy. 8. Department of Motor Sciences and Health, University of Parthenope, Naples, Italy. 9. Department of Medicine and Surgery, Neuroscience Section, University of Salerno, Baronissi, SA, Italy. 10. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy; MRI Research Center SUN-FISM, Second University of Naples, Naples, Italy.
Abstract
INTRODUCTION: To investigate gray matter (GM) and cortical thickness (CTh) changes in patients with Parkinson's disease (PD) with and without Impulse Control Disorders (ICDs). METHODS: Fifteen patients with PD with ICDs (ICD+), 15 patients with PD without ICDs (ICD-) and 24 age and sex-matched healthy controls (HCs) were enrolled in the study. Patients were screened for ICDs by the Minnesota Impulsive Disorders Interview (MIDI) and underwent an extensive neuropsychological evaluation. Whole brain structural imaging was performed on a 3T GE MR scanner. Surface-based investigation of CTh was carried out by using Freesurfer Software. We also used voxel-based morphometry to investigate the pattern of GM atrophy. RESULTS: The voxel-wise analysis of the regional differences in CTh revealed that ICD+ patients showed a statistically significant (p<0.01 FDR) thicker cortex when compared to both ICD- patients and HCs in the anterior cingulate (ACC) and orbitofrontal (OFC) cortices. Moreover, cortical thickness abnormalities were positively correlated with ICD severity (p<0.05 FDR). VBM data did not reveal any statistically significant differences in local GM. CONCLUSIONS: Our results demonstrate that ICD+ patients have an increased CTh in limbic regions when compared with ICD- patients at the same disease stage and with an equal daily levodopa equivalent dose. These corticometric changes may play a role in the lack of inhibition of compulsive behaviors. The presence of such structural abnormalities may result from a synergistic effect of dopaminergic therapy in patients with a pre-existing vulnerability to develop an abnormal behavioral response to external stimuli.
INTRODUCTION: To investigate gray matter (GM) and cortical thickness (CTh) changes in patients with Parkinson's disease (PD) with and without Impulse Control Disorders (ICDs). METHODS: Fifteen patients with PD with ICDs (ICD+), 15 patients with PD without ICDs (ICD-) and 24 age and sex-matched healthy controls (HCs) were enrolled in the study. Patients were screened for ICDs by the Minnesota Impulsive Disorders Interview (MIDI) and underwent an extensive neuropsychological evaluation. Whole brain structural imaging was performed on a 3T GE MR scanner. Surface-based investigation of CTh was carried out by using Freesurfer Software. We also used voxel-based morphometry to investigate the pattern of GM atrophy. RESULTS: The voxel-wise analysis of the regional differences in CTh revealed that ICD+ patients showed a statistically significant (p<0.01 FDR) thicker cortex when compared to both ICD- patients and HCs in the anterior cingulate (ACC) and orbitofrontal (OFC) cortices. Moreover, cortical thickness abnormalities were positively correlated with ICD severity (p<0.05 FDR). VBM data did not reveal any statistically significant differences in local GM. CONCLUSIONS: Our results demonstrate that ICD+ patients have an increased CTh in limbic regions when compared with ICD- patients at the same disease stage and with an equal daily levodopa equivalent dose. These corticometric changes may play a role in the lack of inhibition of compulsive behaviors. The presence of such structural abnormalities may result from a synergistic effect of dopaminergic therapy in patients with a pre-existing vulnerability to develop an abnormal behavioral response to external stimuli.
Authors: F Imperiale; F Agosta; E Canu; V Markovic; A Inuggi; M Jecmenica-Lukic; A Tomic; M Copetti; S Basaia; V S Kostic; M Filippi Journal: Mol Psychiatry Date: 2017-03-07 Impact factor: 15.992
Authors: David Jakabek; Brian D Power; Matthew D Macfarlane; Mark Walterfang; Dennis Velakoulis; Danielle van Westen; Jimmy Lätt; Markus Nilsson; Jeffrey C L Looi; Alexander F Santillo Journal: Hum Brain Mapp Date: 2018-06-20 Impact factor: 5.038
Authors: Marit F L Ruitenberg; Vincent Koppelmans; Tina Wu; Bruno B Averbeck; Kelvin L Chou; Rachael D Seidler Journal: Exp Brain Res Date: 2022-07-19 Impact factor: 2.064
Authors: Santosh K Yadav; Nagarajan Kathiresan; Suyash Mohan; Georgia Vasileiou; Anup Singh; Deepak Kaura; Elias R Melhem; Rakesh K Gupta; Ena Wang; Francesco M Marincola; Arijitt Borthakur; Mohammad Haris Journal: J Neurol Date: 2016-08-20 Impact factor: 4.849